The Cancer Treatment Centers of America (CTCA) isn’t alone in the fight against cancer. CTCA have joined forces with Allscripts and NantHealth to ensure a smooth process that helps doctors overwhelmed by new data when caring for a patient. The use of eviti, a clinical decision support solution allows this to happen.This partnership also allows CTCA to reduce inconsistencies in care. Clinical Pathways enable a greater chance of patients being matched with the proper cancer treatment for their specific diagnosis. Patients can also be approved by insurance providers at a faster rate thanks to accurate data.
While news of CTCA, Allscripts and NantHealth partnering up broke earlier this year, it had been discussed for a little while. Talks began in early 2016 when a need to push an integrated solution forward became apparent. The Chief Executive Officer of Allscripts, Paul Black said CTCA provides “quality care” to its patients. Senior Executive Director of Medical Affairs of NantHealth, Bobby Reddy also praised Cancer Treatment Centers of America and said he was more than happy to work with the network. Under the CTCA are five hospitals with an emphasis on serving cancer patients.
These hospitals are located in the following areas: Philadelphia, Pennsylvania, Tulsa, Oklahoma, and near Atlanta, Georgia; Chicago, Illinois; and Phoenix, Arizona. The network has been serving patients since 1988. Richard J. Stephenson is an investment banker who founded CTCA. He first graduated from Wabash College. He then took his education a step further, graduating from the Northwestern University School of Law. Stephenson founded CTCA when his mother died of bladder cancer. Today, CTCA prides itself on ensuring that only treatment backed by evidence of its effectiveness is used on its patients.